BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 19184984)

  • 21. Structure-activity relationships of 19-norvitamin D analogs having a fluoroethylidene group at the C-2 position.
    Kobayashi E; Shimazaki M; Miyamoto Y; Masuno H; Yamamoto K; DeLuca HF; Yamada S; Shimizu M
    Bioorg Med Chem; 2007 Feb; 15(3):1475-82. PubMed ID: 17110116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells.
    Aguilera O; Peña C; García JM; Larriba MJ; Ordóñez-Morán P; Navarro D; Barbáchano A; López de Silanes I; Ballestar E; Fraga MF; Esteller M; Gamallo C; Bonilla F; González-Sancho JM; Muñoz A
    Carcinogenesis; 2007 Sep; 28(9):1877-84. PubMed ID: 17449905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular basis of the selective activity of vitamin D analogues.
    Carlberg C
    J Cell Biochem; 2003 Feb; 88(2):274-81. PubMed ID: 12520526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. E-cadherin/beta-catenin/T-cell factor pathway is involved in smooth muscle cell proliferation elicited by oxidized low-density lipoprotein.
    Bedel A; Nègre-Salvayre A; Heeneman S; Grazide MH; Thiers JC; Salvayre R; Maupas-Schwalm F
    Circ Res; 2008 Sep; 103(7):694-701. PubMed ID: 18703780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superagonistic fluorinated vitamin D3 analogs stabilize helix 12 of the vitamin D receptor.
    Eelen G; Valle N; Sato Y; Rochel N; Verlinden L; De Clercq P; Moras D; Bouillon R; Muñoz A; Verstuyf A
    Chem Biol; 2008 Oct; 15(10):1029-34. PubMed ID: 18940664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VDR/RXR and TCF4/β-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression.
    Meyer MB; Goetsch PD; Pike JW
    Mol Endocrinol; 2012 Jan; 26(1):37-51. PubMed ID: 22108803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1alpha,25-dihydroxyvitamin D3 inducible transcription factor and its role in the vitamin D action.
    Nezbedova P; Brtko J
    Endocr Regul; 2004 Mar; 38(1):29-38. PubMed ID: 15147236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of TCF-4 expression by VDR and vitamin D in the mouse mammary gland and colorectal cancer cell lines.
    Beildeck ME; Islam M; Shah S; Welsh J; Byers SW
    PLoS One; 2009 Nov; 4(11):e7872. PubMed ID: 19924301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targets of vitamin D receptor signaling in the mammary gland.
    Welsh J
    J Bone Miner Res; 2007 Dec; 22 Suppl 2():V86-90. PubMed ID: 18290729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcription factor Egr1 acts as an upstream regulator of beta-catenin signalling through up-regulation of TCF4 and p300 expression during trans-differentiation of endometrial carcinoma cells.
    Saegusa M; Hashimura M; Kuwata T; Hamano M; Watanabe J; Kawaguchi M; Okayasu I
    J Pathol; 2008 Dec; 216(4):521-32. PubMed ID: 18798221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of hFRNK on E-cadherin/beta-catenin in colon cancer cells in vitro].
    Cao J; Yu JP; Liu CH; Chen XW; Liu S; Luo HS; Yu HG
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):346-50. PubMed ID: 17892129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional activation of the beta-catenin gene at the invasion front of colorectal liver metastases.
    Bandapalli OR; Dihlmann S; Helwa R; Macher-Goeppinger S; Weitz J; Schirmacher P; Brand K
    J Pathol; 2009 Jul; 218(3):370-9. PubMed ID: 19347947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D and prevention of breast cancer.
    Welsh J
    Acta Pharmacol Sin; 2007 Sep; 28(9):1373-82. PubMed ID: 17723171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D receptor levels and binding are reduced in aged rat intestinal subcellular fractions.
    González Pardo V; Boland R; de Boland AR
    Biogerontology; 2008 Apr; 9(2):109-18. PubMed ID: 18060514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
    Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
    Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phytoestrogens regulate transcription and translation of vitamin D receptor in colon cancer cells.
    Gilad LA; Tirosh O; Schwartz B
    J Endocrinol; 2006 Nov; 191(2):387-98. PubMed ID: 17088408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of tumor growth and metastasis by depletion of vesicular sorting protein Hrs: its regulatory role on E-cadherin and beta-catenin.
    Toyoshima M; Tanaka N; Aoki J; Tanaka Y; Murata K; Kyuuma M; Kobayashi H; Ishii N; Yaegashi N; Sugamura K
    Cancer Res; 2007 Jun; 67(11):5162-71. PubMed ID: 17545595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5.
    Peng X; Jhaveri P; Hussain-Hakimjee EA; Mehta RG
    Carcinogenesis; 2007 May; 28(5):1000-7. PubMed ID: 17130524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteopontin gene expression determines spontaneous metastatic performance of orthotopic human breast cancer xenografts.
    Suzuki M; Mose E; Galloy C; Tarin D
    Am J Pathol; 2007 Aug; 171(2):682-92. PubMed ID: 17620367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and activity of vitamin D receptor in the human placenta and in choriocarcinoma BeWo and JEG-3 cell lines.
    Pospechova K; Rozehnal V; Stejskalova L; Vrzal R; Pospisilova N; Jamborova G; May K; Siegmund W; Dvorak Z; Nachtigal P; Semecky V; Pavek P
    Mol Cell Endocrinol; 2009 Feb; 299(2):178-87. PubMed ID: 19133314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.